Breast Cancer |

Breast Cancer research study

What is the primary objective of this study?

Who is eligible to participate?

Inclusion Criteria: - All patients, who are English or Spanish speaking, with a new primary stage 1 or 2 and with tumors > 1 cm or < 1 cm and poorly differentiated breast cancer who have undergone either breast conserving surgery or mastectomy at 1 of 10 participating hospitals in the NY Metropolitan Area. - All surgeons performing breast surgery at study participating hospitals Exclusion Criteria: - Patients with a poor prognosis due to end-stage organ failure or other concomitant conditions such as those undergoing treatment for other cancers

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Breast Cancer

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Other:Systems based intervention tracking oncology consultations and feeding back information to surgeons

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Systems based intervention tracking oncology consultations and feeding back information to surgeons

Control- no interventionUsual Care

Study Status


Start Date: October 2012

Completed Date: May 2016

Phase: N/A

Type: Interventional


Primary Outcome: Change in intervention effect of adjuvant treatment

Secondary Outcome: Organizational Characteristics

Study sponsors, principal investigator, and references

Principal Investigator: Nina A Bickell, MD, MPH

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Collaborator: National Cancer Institute (NCI)

More information:

Discuss Vicodin